tiprankstipranks
Protalix Biotherapeutics (PLX)
NYSE MKT:PLX
Holding PLX?
Track your performance easily

Protalix (PLX) Financial Statements

745 Followers

Protalix Financial Overview

Protalix's market cap is currently ―. The company's EPS TTM is $-0.142; its P/E ratio is -11.46; Protalix is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $0.08. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 17.96M$ 13.47M$ 3.75M$ 10.49M$ 10.35M
Gross Profit$ 9.58M$ 4.02M$ 1.15M$ 1.63M$ 5.45M
EBIT$ 3.84M$ -2.27M$ -4.73M$ -5.65M$ -1.26M
EBITDA$ 4.17M$ -1.95M$ -4.41M$ -5.34M$ -954.00K
Net Income Common Stockholders$ 3.24M$ -2.20M$ -4.59M$ -6.04M$ -1.85M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 27.41M$ 23.40M$ 27.21M$ 23.63M$ 20.41M
Total Assets$ 61.56M$ 91.54M$ 89.83M$ 84.43M$ 87.57M
Total Debt$ 5.68M$ 26.15M$ 26.37M$ 26.28M$ 26.01M
Net Debt$ -21.73M$ 2.75M$ -837.00K$ 2.65M$ 5.60M
Total Liabilities$ 29.13M$ 62.96M$ 60.04M$ 50.87M$ 49.32M
Stockholders Equity$ 32.44M$ 28.58M$ 29.79M$ 33.57M$ 38.25M
Cash Flow-
Free Cash Flow$ 4.02M$ -3.78M$ 3.59M$ 3.35M$ -7.33M
Operating Cash Flow$ 4.11M$ -3.61M$ 4.19M$ 3.60M$ -6.89M
Investing Cash Flow$ 20.33M$ -180.00K$ -606.00K$ -342.00K$ -20.88M
Financing Cash Flow$ -20.42M----
Currency in USD

Protalix Earnings and Revenue History

Protalix Debt to Assets

Protalix Cash Flow

Protalix Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis